Global Aesthetic Medicine Market Size, Status and Forecast 2019-2025
Table of Content
- 1.4.1 Research Process
- 1.4.2 Data Triangulation
- 1.4.3 Research Approach
- 1.4.4 Base Year
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 Global Aesthetic Medicine Quarterly Market Size Analysis
- 2.1 Aesthetic Medicine Business Impact Assessment - COVID-19
- 2.1.1 Global Aesthetic Medicine Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
- 2.2 Global Aesthetic Medicine Quarterly Market Size 2020-2021
- 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
- 2.3.1 Drivers
- 2.3.2 Restraints
- 2.3.3 Opportunities
- 2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
- 3.1 By Players, Global Aesthetic Medicine Quarterly Market Size, 2019 VS 2020
- 3.2 By Players, Aesthetic Medicine Headquarters and Area Served
- 3.3 Date of Key Players Enter into Aesthetic Medicine Market
- 3.4 Key Players Aesthetic Medicine Product Offered
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Aesthetic Medicine Segments, By Type
- 4.1 Introduction
- 1.4.1 Surgical Procedures
- 1.4.2 Non-surgical Procedures
- 4.2 By Type, Global Aesthetic Medicine Market Size, 2019-2021
5 Impact of Covid-19 on Aesthetic Medicine Segments, By Application
- 5.1 Overview
- 5.5.1 Hospitals
- 5.5.2 Ambulatory Surgical Centers
- 5.5.3 Beauty Centers & Medical Spas
- 5.5.4 Dermatology Clinics
- 5.2 By Application, Global Aesthetic Medicine Market Size, 2019-2021
- 5.2.1 By Application, Global Aesthetic Medicine Market Size by Application, 2019-2021
6 Geographic Analysis
- 6.1 Introduction
- 6.2 North America
- 6.2.1 Macroeconomic Indicators of US
- 6.2.2 US
- 6.2.3 Canada
- 6.3 Europe
- 6.3.1 Macroeconomic Indicators of Europe
- 6.3.2 Germany
- 6.3.3 France
- 6.3.4 UK
- 6.3.5 Italy
- 6.4 Asia-Pacific
- 6.4.1 Macroeconomic Indicators of Asia-Pacific
- 6.4.2 China
- 6.4.3 Japan
- 6.4.4 South Korea
- 6.4.5 India
- 6.4.6 ASEAN
- 6.5 Rest of World
- 6.5.1 Latin America
- 6.5.2 Middle East and Africa
7 Company Profiles
- 7.1 Allergan
- 7.1.1 Allergan Business Overview
- 7.1.2 Allergan Aesthetic Medicine Quarterly Revenue, 2020
- 7.1.3 Allergan Aesthetic Medicine Product Introduction
- 7.1.4 Allergan Response to COVID-19 and Related Developments
- 7.2 Alma Laser
- 7.2.1 Alma Laser Business Overview
- 7.2.2 Alma Laser Aesthetic Medicine Quarterly Revenue, 2020
- 7.2.3 Alma Laser Aesthetic Medicine Product Introduction
- 7.2.4 Alma Laser Response to COVID-19 and Related Developments
- 7.3 Cynosure
- 7.3.1 Cynosure Business Overview
- 7.3.2 Cynosure Aesthetic Medicine Quarterly Revenue, 2020
- 7.3.3 Cynosure Aesthetic Medicine Product Introduction
- 7.3.4 Cynosure Response to COVID-19 and Related Developments
- 7.4 Galderma
- 7.4.1 Galderma Business Overview
- 7.4.2 Galderma Aesthetic Medicine Quarterly Revenue, 2020
- 7.4.3 Galderma Aesthetic Medicine Product Introduction
- 7.4.4 Galderma Response to COVID-19 and Related Developments
- 7.5 Lumenis
- 7.5.1 Lumenis Business Overview
- 7.5.2 Lumenis Aesthetic Medicine Quarterly Revenue, 2020
- 7.5.3 Lumenis Aesthetic Medicine Product Introduction
- 7.5.4 Lumenis Response to COVID-19 and Related Developments
- 7.6 Johnson& Johnson
- 7.6.1 Johnson& Johnson Business Overview
- 7.6.2 Johnson& Johnson Aesthetic Medicine Quarterly Revenue, 2020
- 7.6.3 Johnson& Johnson Aesthetic Medicine Product Introduction
- 7.6.4 Johnson& Johnson Response to COVID-19 and Related Developments
- 7.7 Merz Aesthetics
- 7.7.1 Merz Aesthetics Business Overview
- 7.7.2 Merz Aesthetics Aesthetic Medicine Quarterly Revenue, 2020
- 7.7.3 Merz Aesthetics Aesthetic Medicine Product Introduction
- 7.7.4 Merz Aesthetics Response to COVID-19 and Related Developments
- 7.8 PhotoMedex
- 7.8.1 PhotoMedex Business Overview
- 7.8.2 PhotoMedex Aesthetic Medicine Quarterly Revenue, 2020
- 7.8.3 PhotoMedex Aesthetic Medicine Product Introduction
- 7.8.4 PhotoMedex Response to COVID-19 and Related Developments
- 7.9 Syneron Medical
- 7.9.1 Syneron Medical Business Overview
- 7.9.2 Syneron Medical Aesthetic Medicine Quarterly Revenue, 2020
- 7.9.3 Syneron Medical Aesthetic Medicine Product Introduction
- 7.9.4 Syneron Medical Response to COVID-19 and Related Developments
- 7.10 Valeant International
- 7.10.1 Valeant International Business Overview
- 7.10.2 Valeant International Aesthetic Medicine Quarterly Revenue, 2020
- 7.10.3 Valeant International Aesthetic Medicine Product Introduction
- 7.10.4 Valeant International Response to COVID-19 and Related Developments
- 7.11 Zeltiq Aesthetics
- 7.11.1 Zeltiq Aesthetics Business Overview
- 7.11.2 Zeltiq Aesthetics Aesthetic Medicine Quarterly Revenue, 2020
- 7.11.3 Zeltiq Aesthetics Aesthetic Medicine Product Introduction
- 7.11.4 Zeltiq Aesthetics Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
- 9.1 About US
Description
This report covers market size and forecasts of Aesthetic Medicine, including the following market information:
Global Aesthetic Medicine Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Aesthetic Medicine Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Aesthetic Medicine Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Aesthetic Medicine Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Allergan, Alma Laser, Cynosure, Galderma, Lumenis, Johnson& Johnson, Merz Aesthetics, PhotoMedex, Syneron Medical, Valeant International, Zeltiq Aesthetics, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Surgical Procedures
Non-surgical Procedures
Based on the Application:
Hospitals
Ambulatory Surgical Centers
Beauty Centers & Medical Spas
Dermatology Clinics